Lesson
Build the Infection From Surface to System
IE begins when a susceptible endocardial or prosthetic surface meets sustained or transient bloodstream organisms that can adhere, proliferate, and resist host clearance.
- Endothelial injury
- Vegetation
- Biofilm
- Valve destruction
- Embolization
A susceptible native or prosthetic surface collects platelet and fibrin.
Circulating organisms reach and adhere to the thrombotic surface.
Dense growth inside matrix resists immune clearance and drug penetration.
Destruction causes regurgitation while fragments seed distant organs.
Build the vegetation
Endothelial injury promotes platelet and fibrin deposition. Bacteremia introduces organisms with adhesion traits, and the growing vegetation shelters a dense microbial population.
Separate left from right
Left-sided infection can cause systemic emboli and valve failure. Tricuspid and other right-sided infection often produces septic pulmonary emboli.
Recognize risk without stereotyping
Prosthetic valves, prior IE, CIEDs, congenital or structural disease, vascular access, dialysis, healthcare exposure, and injection exposure change probability but do not replace evidence.
Respect the quiet presentation
Fever is common, but a new murmur and classic peripheral findings are not required. Subacute fatigue, weight loss, anemia, renal findings, back pain, or emboli can be the first signal.
Quick check
Lesson
Preserve the Organism Before Treating the Syndrome
Microbiology directs curative therapy. Modern diagnosis uses three culture sets, the 2023 Duke-ISCVID framework, molecular and tissue methods, and a staged blood culture-negative pathway.
- Three culture sets
- 2023 Duke-ISCVID
- Persistent bacteremia
- BCNE
- Molecular diagnosis
Adequate pretherapy volume protects diagnostic yield.
Microbiology, imaging, surgery, pathology, and minor findings combine.
Repeat cultures expose persistent endovascular infection.
After 72 hours, add exposure-guided serology, molecular work, and tissue planning.
Collect cultures first
Obtain three adequately filled blood culture sets from peripheral sites before antibiotics when the patient is stable enough to wait. Bottle volume and prior antimicrobial exposure strongly affect yield.
Use the current criteria
The 2023 Duke-ISCVID criteria retain definite, possible, and rejected categories while expanding typical organisms, molecular methods, prosthetic and device imaging, and surgical evidence.
Document clearance
Repeat cultures every 24 to 48 hours until negative. Persistent recovery requires reassessment of exposure, resistance, abscess, hardware, metastatic foci, and source control.
Escalate culture-negative work
When cultures remain negative after 72 hours, expand exposure-guided serology, molecular testing, valve-tissue planning, pathology, and noninfectious mimics with infectious diseases and microbiology expertise.
Quick check
Lesson
Image the Valve, Then Image the Consequences
Echocardiography establishes valve and device anatomy, while repeat and multimodality imaging answer questions that one negative study cannot settle.
- TTE
- TEE
- Repeat imaging
- Cardiac CT and nuclear imaging
- Embolic survey
Define valve function, vegetation, and hemodynamics.
See prostheses, devices, small lesions, and perivalvular disease.
A negative early study may become diagnostic later.
Answer prosthetic, anatomic, or extracardiac questions.
Start with TTE
Obtain TTE promptly to assess vegetation, regurgitation, ventricular function, hemodynamics, and gross complications.
Escalate to TEE
Use TEE when TTE is negative or inconclusive despite high suspicion and in prosthetic valves, intracardiac devices, S. aureus bacteremia, suspected complications, or surgical planning.
Repeat when biology evolves
Repeat TTE or TEE in 5 to 7 days, or sooner with clinical change, when initial imaging is negative but suspicion remains high.
Add a modality with purpose
Cardiac CT can define perivalvular anatomy. FDG PET CT and WBC imaging can strengthen prosthetic or device assessment. Brain and body imaging can uncover silent emboli and metastatic infection.
Do not anticoagulate the vegetation
IE alone is not an indication to begin antithrombotic therapy. Stroke type, hemorrhage, prosthetic indication, and surgery require multidisciplinary decisions.
Quick check
Lesson
Treat Early Without Freezing the Empiric Regimen
Empiric treatment protects the patient before identification, but it must be tailored to valve type, acquisition, prior therapy, allergy, organ function, and local resistance, then narrowed quickly.
- Valve type
- Acquisition
- Bactericidal exposure
- De-escalation
- Duration clock
Preserve microbiology before therapy when safe.
Valve type and acquisition define initial threats.
Dose, organs, MIC, interactions, and delivery determine activity.
Replace empiric breadth within 24 to 48 hours when possible.
Do not universalize one combination
Stable community native-valve disease differs from early prosthetic, device, healthcare-associated, or septic disease. Vancomycin plus ceftriaxone is not a universal answer.
Protect the cultures
Draw cultures before therapy when safe. Unstable sepsis, shock, acute valve failure, or neurologic emergency requires prompt treatment after rapid specimen collection.
Verify exposure
Use weight, kidney and liver function, infusion strategy, susceptibility, AUC or levels when indicated, drug interactions, and dose receipt to confirm that an active drug is truly active in the patient.
Narrow with ownership
Change empiric therapy to the most effective and least toxic organism-specific regimen as soon as identification and susceptibility permit.
Count from effective therapy
Duration usually begins with effective therapy and bloodstream clearance. Surgery does not automatically restart a full course unless operative cultures or other findings justify it.
Quick check
Lesson
Use Susceptibility to Shorten or Simplify Safely
Oral streptococci, Streptococcus gallolyticus, and HACEK organisms have reliable treatment pathways, but valve type, MIC, complications, kidney function, and source evaluation control the details.
- Viridans streptococci
- Penicillin G
- Ceftriaxone
- Gentamicin boundary
- HACEK
Use penicillin or ceftriaxone for a valve-specific duration.
Reserve gentamicin for uncomplicated low-risk native-valve disease.
Connect the bloodstream isolate to colon evaluation.
Use ceftriaxone and distinguish it from non-HACEK disease.
Treat susceptible oral streptococci
Use penicillin G 12 to 18 million units daily or ceftriaxone 2 g daily for four weeks in uncomplicated native-valve disease and generally six weeks with prosthetic material.
Limit two-week synergy
A two-week beta-lactam plus gentamicin regimen is only for carefully selected uncomplicated susceptible native-valve disease with preserved kidney function and no extracardiac complication.
Investigate S. gallolyticus
Arrange colon evaluation after stabilization because bacteremia or IE has an important association with colorectal neoplasia.
Treat HACEK with ceftriaxone
Ceftriaxone 2 g daily is commonly used for four weeks in native-valve and six weeks in prosthetic-valve HACEK IE. Use ampicillin only when susceptibility is established.
Quick check
Lesson
Prefer the Strongest Staphylococcal Drug and Remove Old Toxicity
S. aureus and coagulase-negative staphylococci can destroy valves rapidly, seed distant sites, persist on hardware, and expose outdated habits such as routine native-valve gentamicin.
- MSSA
- MRSA
- Vancomycin AUC
- Daptomycin
- Prosthetic biofilm
Switch from empiric vancomycin when susceptibility permits.
Use AUC-guided vancomycin or syndrome-matched daptomycin.
Native-valve benefit is unproven and kidney harm increases.
Time rifampin after clearance and evaluate surgery and biofilm.
Switch MSSA to a beta-lactam
Use nafcillin or oxacillin 2 g every 4 hours, or cefazolin 2 g every 8 hours when appropriate, generally for six weeks. Do not keep vancomycin without a compelling reason.
Treat MRSA with verified exposure
Use vancomycin with current AUC-guided practice or daptomycin. FDA-labeled daptomycin is 6 mg/kg daily for S. aureus bacteremia including right-sided IE, while guidelines may use higher doses for difficult MRSA or enterococcal disease.
Remove routine native-valve gentamicin
Aminoglycosides do not improve established outcomes in staphylococcal native-valve IE and increase kidney injury.
Handle prosthetic infection as a team
Rifampin is reserved for susceptible foreign-body infection and is generally delayed until 3 to 5 days of effective therapy after bacteremia clears. Its evidence is weak and its interactions are substantial. Routine adjunctive gentamicin benefit is also uncertain.
Investigate every persistent culture
Search for abscess, infected hardware, metastatic foci, inadequate exposure, resistance, and delayed surgery rather than merely adding drugs.
Quick check
Lesson
Create Synergy Without Losing the Patient
Enterococci require combination logic, while VRE, non-HACEK gram-negative organisms, and fungi require specialized susceptibility, exposure, surgery, and toxicity planning.
- Ampicillin and ceftriaxone
- HLAR
- VRE
- Non-HACEK gram negative
- Fungal IE
Complementary PBP binding treats susceptible E. faecalis.
Aminoglycoside synergy fails with high-level resistance.
Use species, MIC, exposure, combination, and source control.
Non-HACEK and fungi demand specialist and surgical planning.
Use dual beta-lactam therapy for E. faecalis
Ampicillin 2 g every 4 hours plus ceftriaxone 2 g every 12 hours, commonly for six weeks, provides complementary PBP saturation and avoids prolonged aminoglycoside toxicity.
Use aminoglycoside synergy selectively
Verify absence of high-level resistance and monitor levels, kidneys, hearing, and vestibular symptoms if an ampicillin or penicillin plus gentamicin pathway is chosen.
Escalate VRE expertise
Use species, van genotype, daptomycin MIC, prior exposure, and source control to design high-dose daptomycin combination or linezolid-based therapy when appropriate.
Do not collapse rare pathogens together
Non-HACEK gram-negative IE often needs combination and surgery assessment. Fungal IE usually requires early surgery plus prolonged species-directed antifungal therapy and sometimes suppression.
Quick check
Lesson
Recognize When Antibiotics Cannot Repair Anatomy
Heart failure, uncontrolled infection, embolic risk, prosthetic destruction, and infected cardiac hardware require early surgical and multidisciplinary decisions rather than an antibiotic-only plan.
- Heart failure
- Abscess
- Persistent infection
- Embolic prevention
- Device extraction
Severe acute valve dysfunction demands urgent review.
Abscess, fistula, hardware, and bacteremia may require removal.
Balance vegetation anatomy against neurologic timing.
Remove the complete infected system and plan reimplantation deliberately.
Operate for mechanical failure
Acute severe regurgitation, obstruction, fistula, pulmonary edema, or shock requires urgent surgical evaluation while active therapy continues.
Control infection that cannot be sterilized
Abscess, pseudoaneurysm, fistula, dehiscence, new conduction disease, enlarging vegetation, resistant organisms, and persistent cultures can require removal of infected tissue.
Balance embolic prevention with neurologic risk
Vegetation size and mobility, prior emboli, organism, valve dysfunction, ischemic or hemorrhagic stroke, mycotic aneurysm, and operative feasibility determine timing.
Extract infected CIED systems
Definite device infection generally requires complete system extraction, cultures, antimicrobial treatment, temporary rhythm support when necessary, and delayed need-based reimplantation.
Treat the whole person
Include substance use treatment, pain and withdrawal care, harm reduction, housing, access, patient goals, and stigma-free communication in the curative plan.
Quick check
Lesson
Make Every Trend Lead to a Decision
IE monitoring must detect microbiologic failure, mechanical deterioration, embolization, organ toxicity, exposure failure, line harm, and barriers before the patient becomes unstable.
- Culture clearance
- Drug exposure
- Organ toxicity
- OPAT
- Oral consolidation
Document bloodstream sterilization and investigate persistence.
Follow drug-specific kidney, liver, blood, nerve, muscle, and ECG risk.
Move out only after complications and surgery are controlled.
Close doses, response, valve plan, access, and recurrence education.
Monitor the infection and the host
Follow cultures, fever, hemodynamics, examination, CBC, kidney and liver function, inflammatory trajectory, ECG or CK when indicated, new focal symptoms, and valve function.
Interpret drug levels in context
Use current vancomycin AUC-guided practice when feasible. Interpret gentamicin levels only with exact dose and sampling times, and monitor kidney, hearing, and vestibular function.
Use outpatient therapy as consolidation
Consider OPAT or selected oral step-down only after cultures clear, critical complications are controlled, surgery is addressed, the regimen is reliable, monitoring is accessible, and rapid return is possible.
Protect the access plan
Choose the safest delivery route, monitor line complications and adherence, reconcile interactions, and establish missed-dose and symptom escalation pathways.
Close completion deliberately
Confirm dose delivery, culture and clinical response, complication resolution, follow-up imaging plan, valve function, dental care, treatment record, and recurrence instructions.
Quick check
Lesson
Prevent the Cases Prevention Can Actually Reach
Modern prevention prioritizes oral health and reserves a single antibiotic dose for highest-risk cardiac conditions undergoing qualifying dental procedures.
- Highest-risk cardiac conditions
- Qualifying dental procedures
- Amoxicillin
- Allergy alternatives
- No routine nondental prophylaxis
Restrict prophylaxis to highest-risk conditions.
Gingiva, periapical tissue, or oral mucosal perforation must be involved.
Use amoxicillin or a current allergy and route alternative.
Regular care and rapid fever evaluation matter beyond one procedure.
Identify highest-risk conditions
Prophylaxis is reasonable for prosthetic valves including transcatheter prostheses and homografts, prosthetic valve-repair material, prior IE, defined congenital disease, and transplant valve regurgitation from a structurally abnormal valve.
Identify qualifying dental procedures
The procedure must manipulate gingival tissue, the periapical region, or perforate oral mucosa. Routine radiographs, orthodontic adjustment, deciduous tooth shedding, and noninfected anesthetic injection do not qualify.
Use one preprocedure dose
Give amoxicillin 2 g orally 30 to 60 minutes before the procedure. If oral dosing is impossible, use ampicillin 2 g IM or IV, or cefazolin or ceftriaxone 1 g IM or IV when appropriate.
Update the allergy pathway
Oral alternatives include cephalexin 2 g, azithromycin or clarithromycin 500 mg, or doxycycline 100 mg. Avoid cephalosporins after penicillin anaphylaxis, angioedema, or urticaria. Clindamycin is no longer recommended.
Do not extend prophylaxis indiscriminately
Routine prophylaxis is not recommended for TEE, upper or lower endoscopy, colonoscopy, or cystoscopy without active infection. Oral health and regular dental care provide the broader prevention foundation.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 180 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.